PAO Group, Inc. and Puration, Inc. announced the companies will partner on the development of a line of CBD products for Women's Health. PAOG is working closely with Alkame Holdings, Inc. (ALKM) for special packaging requirements. The Women's Health CBD product line will be PAOG and PURA's first product partnership under PURA's Farmersville Hemp Brand initiative.

Last year, PAOG acquired intellectual derived through research into CBD extracted in association with a patented extraction method (U.S. Patent No. 9,199,960). PAOG is developing both pharmaceutical and nutraceutical treatments for humans based on this intellectual property.

PAOG recently announced the launch of its first two CBD nutraceutical products, RelaxRX CBD, a sleep aid, and RehabRX CBD, a salve. PAOG has confirmed shipping its first and second CBD nutraceutical product to its distribution partner, North American Cannabis Holdings, Inc. (USOTC: USMJ). Even before the product has been set up for sale online at www.USMJ.com, inquires for the product have indicated a rapid sellout.

PAOG is on track to realize its first revenue this year, starting in Fourth Quarter 2021, since acquiring the extraction technology. PAOG expects revenue to grow rapidly following its first two CBD nutraceutical product launches as the company has follow on products lined up to follow these products adding to overall sales potential.